Abstract

BackgroundStem cells from apical papilla (SCAP) are a subpopulation of mesenchymal stem cells (MSCs) isolated from the apical papilla of the developing tooth root apex of human teeth. Because of their osteogenic/dentinogenic capacity, SCAP are considered as a source for bone and dentin regeneration. However, little is understood about the molecular mechanism of osteogenic/dentinogenic differentiation of SCAP. Phosphoinositide 3 kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) signal pathway participates in regulating the differentiation of various cell types, such as MSCs. In this study, we examined the role of the PI3K-AKT-mTOR signal pathway in the osteogenic/dentinogenic differentiation of SCAP. Moreover, we challenge to fabricate scaffold-free SCAP-based spheroidal calcified constructs.MethodsSCAP were pretreated with or without small interfering RNA for AKT (AKT siRNA), PI3K inhibitor LY294402, and mTOR inhibitor rapamycin and were cultured under osteogenic/dentinogenic differentiation to examine in vitro and in vivo calcified tissue formation. Moreover, SCAP-based cell aggregates were pretreated with or without LY294402 and rapamycin. The cell aggregates were cultured under osteogenic/dentinogenic condition and were analyzed the calcification of the aggregates.ResultsPretreatment with AKT siRNA, LY294402, and rapamycin enhances the in vitro and in vivo calcified tissue-forming capacity of SCAP. SCAP were fabricated as scaffold-free spheroids and were induced into forming calcified 3D constructs. The calcified density of the spheroidal constructs was enhanced when the spheroids were pretreated with LY294402 and rapamycin.ConclusionsOur findings indicate that the suppression of PI3K-AKT-mTOR signal pathway plays a role in not only enhancing the in vivo and in vitro osteogenic/dentinogenic differentiation of SCAP, but also promoting the calcification of scaffold-free SCAP-based calcified constructs. These findings suggest that a suppressive regulation of PI3K-AKT-mTOR signal pathway is a novel approach for SCAP-based bone and dentin regeneration.

Highlights

  • Stem cells from apical papilla (SCAP) are a subpopulation of mesenchymal stem cells (MSCs) isolated from the apical papilla of the developing tooth root apex of human teeth

  • Given the post neural crest stem cell property of SCAP [9], the signals related to TGFβ/TBR are believed to participate in the maintenance of the stemness and regulation of the osteogenic/dentinogenic capacity of SCAP [10]

  • To understand the role of Phosphoinositide 3 kinase (PI3K)-AKTmTOR signal pathway in the osteogenic/dentinogenic differentiation of SCAP, we examined the effect of the interfering RNA (AKT siRNA) for AKT and specific inhibitors for PI3K and mammalian target of rapamycin (mTOR), LY204402 and rapamycin, respectively

Read more

Summary

Introduction

Stem cells from apical papilla (SCAP) are a subpopulation of mesenchymal stem cells (MSCs) isolated from the apical papilla of the developing tooth root apex of human teeth. Because of their osteogenic/dentinogenic capacity, SCAP are considered as a source for bone and dentin regeneration. The stem cells that can be isolated from the apical papilla tissues of the developing tooth root apex of human permanent teeth, such as impacted third molars, are termed stem cells from apical papilla (SCAP) [1]. Given the post neural crest stem cell property of SCAP [9], the signals related to TGFβ/TBR are believed to participate in the maintenance of the stemness and regulation of the osteogenic/dentinogenic capacity of SCAP [10]. No study has reported the involvement of PI3K-AKT-mTOR signal pathway in the osteogenic/dentinogenic differentiation of SCAP

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call